A few days ago, I posted something about a clinical trial of a monoclonal antibody still accepting enrollees in Europe. I’ve since discovered that that’s incorrect, and that trial is filled. Sorry for the error. I’ve taken down that post.

But several other trials are coming down the pipeline in Europe, North America and elsewhere in the next few months. I’ll keep you informed (best I can).